Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A multi-institutional study of renal outcomes and renal-related pregnancy outcomes in uterus transplant recipients

D. Sawinski, L. Johannesson, J. Kristek, J. Fronek, KE. O'Neill, A. Gregg, G. Testa, PM. Porrett

. 2022 ; 22 (12) : 3101-3110. [pub] 20220723

Jazyk angličtina Země Spojené státy americké

Typ dokumentu multicentrická studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032495

Uterus transplantation (UTx) is an effective treatment option for uterine factor infertility. However, the need for immunosuppression and congenital renal anomalies that coexist with uterine agenesis in about 30% of women with Mayer-Rokitansky-Kuster-Hauser syndrome create a risk for renal dysfunction. We therefore examined renal function trajectory and related pregnancy complications in an international cohort of 18 UTx recipients from September 2016-February 2020 who had at least one live birth. All UTx recipients had a diminution in their renal function that was apparent starting at 30 days posttransplant and in half the reduction in eGFR was at least 20%; the decrease in eGFR persisted into the early post-partum period. Half met criteria for Stage 1 acute kidney injury (AKI) as defined by the AKI Network criteria during their pregnancy. Overall, 28% of UTx recipients developed pre-eclampsia. eGFR was lower at embryo transfer and throughout pregnancy among those who developed pre-eclampsia, reaching statistical significance at week 16 of pregnancy. This effect was independent of tacrolimus levels. Mean eGFR remained significantly lower in the first 1-3 months after delivery. In the subgroup who reached 12 months of postpartum follow up and had a graft hysterectomy (n = 4), there was no longer a statistical difference in eGFR (pretransplant 106.7 ml/m ± 17.7 vs. 12 mos postpartum 92.6 ml/m ± 21.7, p = .13) but the number was small. Further study is required to delineate long term renal risks for UTx recipients, improve patient selection, and make decisions regarding a second pregnancy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032495
003      
CZ-PrNML
005      
20230131151317.0
007      
ta
008      
230120s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ajt.17149 $2 doi
035    __
$a (PubMed)35822437
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sawinski, Deirdre $u Division of Nephrology and Transplantation, Weill Cornell Medical College, New York, New York, USA $1 https://orcid.org/0000000179038295
245    12
$a A multi-institutional study of renal outcomes and renal-related pregnancy outcomes in uterus transplant recipients / $c D. Sawinski, L. Johannesson, J. Kristek, J. Fronek, KE. O'Neill, A. Gregg, G. Testa, PM. Porrett
520    9_
$a Uterus transplantation (UTx) is an effective treatment option for uterine factor infertility. However, the need for immunosuppression and congenital renal anomalies that coexist with uterine agenesis in about 30% of women with Mayer-Rokitansky-Kuster-Hauser syndrome create a risk for renal dysfunction. We therefore examined renal function trajectory and related pregnancy complications in an international cohort of 18 UTx recipients from September 2016-February 2020 who had at least one live birth. All UTx recipients had a diminution in their renal function that was apparent starting at 30 days posttransplant and in half the reduction in eGFR was at least 20%; the decrease in eGFR persisted into the early post-partum period. Half met criteria for Stage 1 acute kidney injury (AKI) as defined by the AKI Network criteria during their pregnancy. Overall, 28% of UTx recipients developed pre-eclampsia. eGFR was lower at embryo transfer and throughout pregnancy among those who developed pre-eclampsia, reaching statistical significance at week 16 of pregnancy. This effect was independent of tacrolimus levels. Mean eGFR remained significantly lower in the first 1-3 months after delivery. In the subgroup who reached 12 months of postpartum follow up and had a graft hysterectomy (n = 4), there was no longer a statistical difference in eGFR (pretransplant 106.7 ml/m ± 17.7 vs. 12 mos postpartum 92.6 ml/m ± 21.7, p = .13) but the number was small. Further study is required to delineate long term renal risks for UTx recipients, improve patient selection, and make decisions regarding a second pregnancy.
650    _2
$a těhotenství $7 D011247
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a výsledek těhotenství $7 D011256
650    12
$a ženská infertilita $7 D007247
650    _2
$a příjemce transplantátu $7 D066027
650    12
$a preeklampsie $7 D011225
650    _2
$a uterus $x transplantace $x abnormality $7 D014599
650    _2
$a ledviny $x fyziologie $7 D007668
650    12
$a akutní poškození ledvin $7 D058186
655    _2
$a multicentrická studie $7 D016448
655    _2
$a časopisecké články $7 D016428
700    1_
$a Johannesson, Liza $u Division of Obstetrics and Gynecology, Baylor University Medical Center, Dallas, Texas, USA $u Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas, USA $1 https://orcid.org/0000000185723811
700    1_
$a Kristek, Jakub $u Department of Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Anatomy, Second Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000237582273
700    1_
$a Fronek, Jiri $u Department of Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Anatomy, Second Faculty of Medicine, Charles University, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a O'Neill, Kathleen E $u University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA $1 https://orcid.org/0000000319806840
700    1_
$a Gregg, Anthony $u Department of Obstetrics and Gynecology, Prisma Health, Columbia, South Carolina, USA
700    1_
$a Testa, Giuliano $u Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas, USA
700    1_
$a Porrett, Paige M $u Comprehensive Transplant Institute, University of Alabama at Birmingham, Birmingham, Alabama, USA $1 https://orcid.org/0000000268955597
773    0_
$w MED00006447 $t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons $x 1600-6143 $g Roč. 22, č. 12 (2022), s. 3101-3110
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35822437 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151313 $b ABA008
999    __
$a ok $b bmc $g 1891323 $s 1183830
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 22 $c 12 $d 3101-3110 $e 20220723 $i 1600-6143 $m American journal of transplantation $n Am J Transplant $x MED00006447
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace